MHRA Drug Safety Update November 2020
MHRA Drug Safety Update November 2020
November 18, 2020
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 14 Issue 4 November 2020) has been published and includes articles on:
- Modafinil (Provigil): increased risk of congenital malformations if used during pregnancy
- Pirfenidone (Esbriet): risk of serious liver injury, and updated advice on liver function testing
- Ferric carboxymaltose (Ferinject▼): risk of symptomatic hypophosphataemia leading to osteomalacia and fractures
- Bupropion (Zyban): risk of serotonin syndrome with use with other serotonergic drugs
- Isotretinoin (Roaccutane▼): contribute to expert review
- Letters and drug alerts sent to healthcare professionals in October 2020
To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website
Posted in: Dispensing & Supply, PSNC News
